Meptazinol
From Wikipedia, the free encyclopedia
Meptazinol
|
|
Systematic (IUPAC) name | |
3-(3-ethyl-1-methylazepan-3-yl)phenol | |
Identifiers | |
CAS number | |
ATC code | N02 |
PubChem | |
Chemical data | |
Formula | C15H23NO |
Mol. mass | 233.34922 g/mol |
SMILES | & |
Synonyms | Meptid |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Dependence Liability | Low |
Routes | Oral, IM, IV |
Meptazinol (Meptid) is an opioid analgesic for use with moderate to severe pain, most commonly used to treat pain in obstetrics (childbirth). A partial µ-opioid receptor agonist, its mixed agonist/antagonist activity affords it a lower risk of dependence and abuse than full µ agonists like morphine. Meptazinol exhibits a short onset of action, but also a shorter duration of action relative to other opioids such as morphine, pentazocine, or buprenorphine.[1]
[edit] References
- ^ Holmes B, Ward A. "Meptazinol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy." Drugs. 1985 Oct; 30(4):285-312. PMID 2998723